Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

• Main Authors: Mehdi Sowlati (Author), Silviu-Horia Morariu (Author), Olguta Orzan (Author), Stefano Veraldi (Author), Roni P. Dodiuk-Gad (Author), Remus I. Orasan (Author), Cristian Gainaru (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydro...